Observation of metastable Aβ amyloid protofibrils by atomic force microscopy
暂无分享,去创建一个
Peter T. Lansbury | Charles M. Lieber | Stanislaus S. Wong | P. Lansbury | C. Lieber | S. Wong | J. Harper | James Harper
[1] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[2] H. Vinters,et al. Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[3] David Keller,et al. Scanning Force Microscopy in Biology , 1995 .
[4] W. B. Stine,et al. The nanometer-scale structure of amyloid-Β visualized by atomic force microscopy , 1996 .
[5] C. Glabe,et al. Surfactant properties of Alzheimer's A beta peptides and the mechanism of amyloid aggregation. , 1994, The Journal of biological chemistry.
[6] Weiming Xia,et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice , 1997, Nature Medicine.
[7] P. Lansbury,et al. Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.
[8] Kenneth S. Kosik,et al. The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology , 1996, Nature Medicine.
[9] S. Younkin,et al. Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.
[10] T. Iwatsubo,et al. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43) , 1994, Neuron.
[11] P. Fraser,et al. Morphology and antibody recognition of synthetic β‐amyloid peptides , 1991 .
[12] B. Yankner,et al. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[13] Allan I. Levey,et al. Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo , 1996, Neuron.
[14] P. Lansbury,et al. Molecular determinants of amyloid deposition in Alzheimer's disease: conformational studies of synthetic beta-protein fragments. , 1990, Biochemistry.
[15] H. Naiki,et al. First-order kinetic model of Alzheimer's beta-amyloid fibril extension in vitro. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[16] S. Younkin,et al. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. , 1994, Science.
[17] P. Lansbury,et al. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[18] D. Selkoe,et al. Normal and abnormal biology of the beta-amyloid precursor protein. , 1994, Annual review of neuroscience.
[19] C F Quate,et al. Imaging crystals, polymers, and processes in water with the atomic force microscope. , 1989, Science.
[20] P. Lansbury,et al. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.
[21] J. Loike,et al. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils , 1996, Nature.
[22] P. Fraser,et al. pH-dependent structural transitions of Alzheimer amyloid peptides. , 1991, Biophysical journal.
[23] Eric J. Simon,et al. Structural model for the β-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide , 1995, Nature Structural Biology.
[24] T. Holzman,et al. Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths. , 1994, Biophysical journal.
[25] P E Fraser,et al. Examination of the structure of the transthyretin amyloid fibril by image reconstruction from electron micrographs. , 1995, Journal of molecular biology.
[26] R. Wetzel,et al. Native complex formation between apolipoprotein E isoforms and the Alzheimer's disease peptide A beta. , 1996, Biochemistry.
[27] J. Hardy,et al. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1 , 1996, Nature.
[28] Louise C. Serpell,et al. Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous β-sheet helix , 1996 .
[29] Peter T. Lansbury,et al. A REDUCTIONIST VIEW OF ALZHEIMER'S DISEASE , 1996 .
[30] D. Kirschner,et al. On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[31] G. Schellenberg,et al. Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease , 1996, Nature Medicine.